Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
FibroGen to present FG-4592 phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia

FibroGen to present FG-4592 phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia

ENERCA network organizes European Symposium on rare anemias

ENERCA network organizes European Symposium on rare anemias

ACE-041 drug may provide new option to treat cancer

ACE-041 drug may provide new option to treat cancer

YM BioSciences expands CYT387 Phase I/II clinical trial for myelofibrosis in five sites

YM BioSciences expands CYT387 Phase I/II clinical trial for myelofibrosis in five sites

Health literacy leads to less hospitalization for heart failure

Health literacy leads to less hospitalization for heart failure

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Isis, Xenon enter collaboration to discover and develop antisense drugs for AI

Isis, Xenon enter collaboration to discover and develop antisense drugs for AI

Children's Hospital pediatric immunologist collaborates with European gene therapy researchers to study WAS syndrome

Children's Hospital pediatric immunologist collaborates with European gene therapy researchers to study WAS syndrome

FDA approves Halaven therapy for metastatic late-stage breast cancer

FDA approves Halaven therapy for metastatic late-stage breast cancer

RBC boosting drugs may undermine breast cancer treatment with Herceptin

RBC boosting drugs may undermine breast cancer treatment with Herceptin

New mathematical model may help predict anemia risk

New mathematical model may help predict anemia risk

AmerisourceBergen increases quarterly dividend 25% to $0.10 per common share

AmerisourceBergen increases quarterly dividend 25% to $0.10 per common share

Forest enters commercialization collaboration with Janssen for Bystolic and Savella in Canada

Forest enters commercialization collaboration with Janssen for Bystolic and Savella in Canada

HemaCAM computer-assisted blood cell analysis system automates assessment of blood counts

HemaCAM computer-assisted blood cell analysis system automates assessment of blood counts

NJIT expert to discuss history of sickle cell disease at NIH symposium

NJIT expert to discuss history of sickle cell disease at NIH symposium

Incyte presents data on INCB28050 Phase IIa trial for rheumatoid arthritis at ACR/ARHP Meeting

Incyte presents data on INCB28050 Phase IIa trial for rheumatoid arthritis at ACR/ARHP Meeting

Human blood from adult human skin

Human blood from adult human skin

New data on Soliris for PNH treatment to be presented at ASH Annual Meeting

New data on Soliris for PNH treatment to be presented at ASH Annual Meeting

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.